- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT04926337
Preoxygenation With High-flow Nasal Oxygen in Adult Trauma Patients During Rapid Sequence Induction Anaesthesia (PRIOR-Trauma)
Preoxygenation With High-flow Nasal Oxygen in Comparison to Standard Face Mask in Adult Trauma Patients During Rapid Sequence Induction Anesthesia- a Prospective, Non-randomized, Before-and-after Study
Previous studies investigating apnoea oxygenation has shown that delivering oxygen via a high flow can maintain adequate oxygen saturation levels in a patient for over 30 minutes.
It has recently been demonstrated, in several studies, that High Flow Nasal Oxygen (HFNO) used during preoxygenation in patients undergoing emergency surgery is at least equally effective as preoxygenation with standard tight fitting mask. Data from these recent studies investigating arterial oxygen saturation levels during rapid sequence induction anaesthesia have not been able to detect any difference between the two methods. The mean apnea time among the patients in the previous studies have been relatively short.
Patients suffering traumatic injuries could be more prone to desaturate during prolonged apnea due to being hemodynamic unstable or suffering injuries to the respiratory tract.
Based on the above, the aim is now to conduct a trial where trauma patients are preoxygenated with high flow nasal oxygen before anaesthetised with rapid sequence induction (RSI) technique. The trial is set to be a before-and-after study. During approximately 6 to 9 months data will be registered from trauma patients undergoing emergency anaesthesia where preoxygenation is performed according to standard rutin, with traditional facemask. During the coming six to nine months trauma patients undergoing emergency anaesthesia will be preoxygenated with high flow nasal oxygen. Data will be registered and compared to the data collected from the patients preoxygenated with facemark.
The general purpose of this project is to compare the preoxygenation technique based on HFNO with traditional preoxygenation with a tight fitting mask, with the main focus being oxygen saturation levels, during rapid sequence induction (RSI) intubation in trauma patients in need of immediate anaesthesia.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Voraussichtlich)
Kontakte und Standorte
Studienkontakt
- Name: Malin Jonsson Fagerlund
- Telefonnummer: 0707691405
- E-Mail: malin.jonsson-fagerlund@sll.se
Studienorte
-
-
-
Stockholm, Schweden, SE-17176
- Rekrutierung
- Karolinska University Hospital Solna
-
Kontakt:
- Malin Jonsson Fagerlund
- Telefonnummer: +46707691405
- E-Mail: malin.jonsson.fagerlund@ki.se
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- 1 Adult, ≥18 years old
- 2 Level 1 trauma with patients in need of emergency anaesthesia before leaving the trauma unit (trauma room or nearby operating theatre).
Exclusion Criteria:
- 1 Patients with or with risk of skull or facial injuries where application of nasal cannula is decided to be avoided by the trauma team.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
---|---|
Tight fitting facemask
Preoxygenation with tight facemask, 100% oxygen.
|
Preoxygenation with tight facemask, 10 L/min, 100% oxygen.
|
High flow nasal oxygen
Preoxygenation with high flow nasal oxygen, 100% oxygen
|
Preoxygenation with high flow nasal oxygen, 40-70 L/min, 100% oxygen.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Number of patients with a peripheral oxygen saturation (SpO2) below 93%
Zeitfenster: From start of anaesthesia until 1 minute after tracheal intubation.
|
Compare the number of patients with a peripheral oxygen saturation (SpO2) below 93% from induction of anesthesia (when induction drug is administered) until one minute after intubation between the group preoxygenated using HFNO and the group preoxygenated with traditional tight-fitting mask.
|
From start of anaesthesia until 1 minute after tracheal intubation.
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Lowest median SpO2.
Zeitfenster: From start of anaesthesia until 1 minute after tracheal intubation.
|
Lowest median SpO2 during preoxygenation using HFNO compared to traditional preoxygenation from when first anesthetic drug is administered until 1 minute after intubation
|
From start of anaesthesia until 1 minute after tracheal intubation.
|
End tidal gas levels
Zeitfenster: At the first breath after tracheal intubation.
|
Difference in levels of ETO2 and ETCO2 in the first breath after intubation with HFNO oxygenation compared to traditional pre-oxygenation.
|
At the first breath after tracheal intubation.
|
Time span from start of preoxygenation until intubation.
Zeitfenster: Could vary depending on patient and trauma, from a couple of minutes up to 20-30 minutes.
|
Compare the time span from start of preoxygenation until intubation between the HFNO group and the group with traditional preoxygenation.
|
Could vary depending on patient and trauma, from a couple of minutes up to 20-30 minutes.
|
Time span from entering trauma room until intubation.
Zeitfenster: Could vary depending on patient and trauma, from a couple of minutes up to an hour.
|
Time span from when the patient enters the trauma room until intubation in the HFNO group compared to the group with traditional preoxygenation.
|
Could vary depending on patient and trauma, from a couple of minutes up to an hour.
|
Difficulties with induction of anaesthesia
Zeitfenster: Could vary depending on patient and trauma, from a couple of minutes up to 20-30 minutes.
|
Compare the perceived difficulties during induction of anaesthesia between the HFNO technique and traditional preoxygenation, for example tolerance to mask or nasal cannula
|
Could vary depending on patient and trauma, from a couple of minutes up to 20-30 minutes.
|
Frequency of complications
Zeitfenster: Could vary depending on patient and trauma, from a couple of minutes up to 20-30 minutes.
|
Frequency of complications (aspiration, signs of intraabdominal/intracranial gas, difficulties intubating the trachea, hypotension) in the HFNO group compared to the group preoxygenated with traditional facemask.
|
Could vary depending on patient and trauma, from a couple of minutes up to 20-30 minutes.
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Malin Jonsson Fagerlund, Karolinska University Hospital and Karolinska Institute
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Voraussichtlich)
Studienabschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- PRIOR-Trauma
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Tight Fitting Facemask
-
Lumenis Be Ltd.UnbekanntVagina-AtrophieVereinigte Staaten
-
Lumenis Be Ltd.AbgeschlossenZur Überprüfung der Gewebeerwärmung sowie der Temperaturstabilität und -sicherheit während der gesamten HF-Behandlungsdauer im GesichtVereinigte Staaten
-
Shanghai Zhongshan HospitalJining Medical University; Cancer Hospital of Guangxi Medical UniversityAktiv, nicht rekrutierend
-
Fudan UniversityZurückgezogenIntrahepatisches CholangiokarzinomChina
-
Universidad Complutense de MadridAbgeschlossenDiabetischer Fuß | Orthopädische Störung | FußknöchelverletzungenSpanien
-
Ain Shams UniversityAbgeschlossenGlaukom, offener Winkel
-
Krankenhaus BruneckMedical University InnsbruckAbgeschlossenHerzstillstandItalien
-
The Hospital for Sick ChildrenAbgeschlossenEpilepsie | Schlaflosigkeit | EntwicklungsstörungKanada